47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
86.10.Z - Hospital activities
86.90.A - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,9 | 1,6 | 1,2 | -25,1 |
Gross profit (loss) | 2,1 | 1,8 | 1,1 | -37,7 |
EBITDA | 2,2 | 1,7 | 1,1 | -34,3 |
Short time liabilities | 0,8 | 0,9 | 1,6 | 78,3 |
Other operating costs | 0,1 | 0,1 | 0,1 | 27,5 |
Equity capital | 7,7 | 7,8 | 7,1 | -8,9 |
Operating profit (EBIT) | 1,9 | 1,5 | 1,1 | -24,3 |
Assets | 10,7 | 10,5 | 10,4 | -0,6 |
Net profit (loss) | 2,1 | 1,8 | 1,1 | -37,7 |
Cash | 2 | 0,7 | 0,7 | -9,8 |
Net income from sale | 10,3 | 10,5 | 10,5 | 0,4 |
Liabilities and provisions for liabilities | 3 | 2,7 | 3,3 | 23,9 |
Working assets | 3,1 | 2,1 | 2 | -2,9 |
Other income costs | 0,2 | 0 | 0,1 | 179 |
Depreciation | 0,3 | 0,2 | 0 | -97,1 |
% | % | % | p.p. | |
Profitability of capital | 27 | 23,4 | 16 | -7,4 |
Equity capital to total assets | 72,1 | 74,7 | 68,5 | -6,2 |
Gross profit margin | 20,2 | 17,4 | 10,8 | -6,6 |
EBITDA Margin | 21,4 | 16,5 | 10,8 | -5,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 31 | 55 | 24 |
Current financial liquidity indicator | 3.7987892627716064 | 2.342853307723999 | 1.275246500968933 | -1 |
Net dept to EBITDA | 0.1390022337436676 | 0.5961607098579407 | 0.9137704372406006 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane